BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Intestine
,
Personalized medicine
,
Lipopolysaccharide
,
rs6983267
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TARS
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Oral mucosa
Peritoneum
Hematopoietic stem cell of bone marrow
Esophagus
Colon mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
ThrRS is a novel regulator of STAT3 activation.
Threonyl-tRNA synthetase gene, a potential target for RNAi-based control of three rice planthoppers.
A non-translational role of threonyl-tRNA synthetase in regulating JNK signaling during myogenic dif…
Identification of bacteria-selective threonyl-tRNA synthetase substrate inhibitors by structure-base…
Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder
Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer
Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting …
Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer
A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calm…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ